3 days ago
2
natatravel/iStock via Getty Images
Regencell Bioscience (NASDAQ:RGC) ended a 10-day losing streak on Thursday to climb ~120%, extending its YTD jump to over 180-fold, days after the Chinese biotech blamed short sellers, among other factors, for its extreme share price volatility.
With nearly 94% of
English (US) ·